Lessons Learned from C1q Inhibition in Neurodegenerative Conditions
Time: 9:30 am
day: Conference Day One
Details:
- Understanding the basic scientific mechanism behind C1q inhibition in neurodegenerative diseases
- Explore how complement’s role in the pathophysiology of neurodegenerative diseases influenced the scientific rationale behind targeting C1q
- Hear the lessons learned by Annexon in targeting C1q for Guillain-Barré syndrome, Huntington’s Disease and Amyotrophic Lateral Sclerosis
